Stavzor

Stavzor is a brand name of valproic acid, approved by the FDA in the following formulation(s):

STAVZOR (valproic acid - capsule, delayed release; oral)

• 
  Manufacturer: BANNER PHARMACAPS
  
  Approval date: July 29, 2008
  
  Strength(s): 125MG, 250MG, 500MG ^[RLD]

Has a generic version of Stavzor been approved?

No. There is currently no therapeutically equivalent version of Stavzor available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Stavzor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Stavzor.

See also...

• Stavzor Consumer Information (Drugs.com)
• Stavzor Delayed-Release Capsules Consumer Information (Wolters Kluwer)
• Stavzor Consumer Information (Cerner Multum)
• Stavzor Advanced Consumer Information (Micromedex)
• Valproate Consumer Information (Wolters Kluwer)
• Valproate Syrup Consumer Information (Wolters Kluwer)
• Valproic Acid Consumer Information (Wolters Kluwer)
• Valproic Acid Delayed-Release Capsules Consumer Information (Wolters Kluwer)
• Valproic Acid Syrup Consumer Information (Wolters Kluwer)
• Valproic acid Consumer Information (Cerner Multum)
• Alti-Valproic Advanced Consumer Information (Micromedex)
• Depakote Advanced Consumer Information (Micromedex)
• Depakote DR Advanced Consumer Information (Micromedex)
• Depakote ER Advanced Consumer Information (Micromedex)
• Depakote Sprinkles Advanced Consumer Information (Micromedex)
• Epiject Iv Advanced Consumer Information (Micromedex)
• Valproate sodium Intravenous Advanced Consumer Information (Micromedex)
• Valproic acid Advanced Consumer Information (Micromedex)